Jacek Jassem

1951 -

foto: Wikimedia Commons

land van nationaliteit: Polen

moedertaal: Pools

taalbeheersing: Pools

opleiding gevolgd aan: Medical University of Gdańsk

beroep: arts, lecturer, onderzoeker, oncoloog

onderscheiding: Medaille van de Nationale Onderwijs Commissie, Ridder in de Orde van Polonia Restituta, Gouden kruis van verdienste (Polen), Silver Cross of Merit, Jan Heweliusz Scientific Award of the City of Gdańsk

Jacek Jassem (ur. 21 października 1951 w Krakowie) – polski onkolog i nauczyciel akademicki, profesor nauk medycznych, profesor zwyczajny Gdańskiego Uniwersytetu Medycznego. Source: Wikipedia (pl)

Series

There is nothing here

Create a new serie

Werken

There is nothing here

Create a new work

Artikels 381

Date

Titel

Auteurs

2022-11-15

The need for a comprehensive and integrated approach to lung cancer policy in Europe

Tit Albreht, Anne-Marie Baird, Jacek Jassem
2021-06-20

imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnostics

Anna Supernat, Tomasz Stokowy, Jacek Jassem
2021-08-03

Transcriptomic landscape of blood platelets in healthy donors

Marta Popeda, Tomasz Stokowy, Jacek Jassem
2020-02-03

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations

Jacek Jassem, Renata Duchnowska, Janusz Milanowski
2020-01-15

Nazartinib in EGFR Thr790Met-mutant non-small-cell lung cancer

Rafal Dziadziuszko, Jacek Jassem
2020-08-01

Lung Cancer in Poland

Rafal Dziadziuszko, Maciej Krzakowski, Rodryg Ramlau, Katarzyna Dziadziuszko, Jacek Jassem, Joanna Chorostowska-Wynimko, Wojciech Biernat, Tomasz Grodzki, Joanna Didkowska, Jacek Niklinski, Renata Langfort
2020-08-01

Multidisciplinary team care in advanced lung cancer

Jacek Jassem
2020-10-01

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC

Jacek Jassem, Giuseppe Giaccone
2020-11-05

Comparison of claudin-3 and claudin-4 expression in bilateral and unilateral breast cancer

Jacek Jassem, Wojciech Biernat, Elżbieta Senkus, M Swierblewski, Jolanta Szade
2020-11-25

ALK alterations in salivary gland carcinomas

Wojciech Biernat, Adam Gorczyński, Jacek Jassem, Rafal Dziadziuszko, Roopika Menon, Piotr Czapiewski, Mariola Iliszko
2019-12-01

Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach

Jacek Jassem
2019-09-12

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Robin L Jones, Robert G. Maki, Jacek Jassem, Mark J Ratain
2019-11-29

Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis

Christiane Thallinger, Jacek Jassem
2019-01-01

Indeed, Nuance Matters

Jacek Jassem
2019-11-01

Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens

Richard Sullivan, Jacek Jassem
2019-02-01

Prognostic value of broad-spectrum keratin clones AE1/AE3 and CAM5.2 in small cell lung cancer patients undergoing pulmonary resection

Jacek Jassem, Adam Gorczyński, Wojciech Biernat, Piotr Czapiewski
2019-07-18

International multidisciplinary expert panel consensus on breast reconstruction and radiotherapy

John R. Benson, Z E Winters, Nicola Rocco, Corydon Hammond, Jacek Jassem
2019-06-01

Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC

Jacek Jassem, Tomasz Burzykowski
2019

Folate/homocysteine metabolism and lung cancer risk among smokers

Janusz Limon, Jacek Jassem, A Stanisławska-Sachadyn, Rafal Dziadziuszko, Witold Rzyman, Joanna Borzyszkowska
2019-05-01

Lung cancer: a preventable disease.

Jacek Jassem
2019-05-01

Tobacco smoking after diagnosis of cancer: clinical aspects.

Jacek Jassem
2018-02-09

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Fabio Piscaglia, Masatoshi Kudo, Jacek Jassem, Kenji Ikeda
2018-10-01

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Fabrice André, Angelo Di Leo, Eric P. Winer, Emiel Rutgers, Jacek Jassem
2018-04-05

Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer

Marcin Skrzypski, Jacek Jassem
2018-05-09

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

Francesco Grossi, Marcello Tiseo, Alessandra Bearz, Jacek Jassem
2018-06-04

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

Paweł Wiechno, Jacek Jassem, Fred Saad
2018-08-24

Erlotinib as adjuvant therapy in EGFR-mutant NSCLC

Jacek Jassem
2018-09-04

Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe

Zarko Bajić, Jacek Jassem
2018-11-26

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Evandro de Azambuja, Angelo Di Leo, Jacek Jassem, Patrick Neven, Aron Goldhirsch, Beat Thürlimann
2018-08-17

Can an Integrative SNP Approach Substitute Standard Identification in Comprehensive Case/Control Analyses?

Anna Papiez, Marcin Skrzypski, Rafal Dziadziuszko, Joanna Polanska, Jacek Jassem
2018-02-06

MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma

Marcin Skrzypski, Tomasz Stokowy, Grzegorz Stasilojc, Anna Supernat, Anna J Zaczek, Jacek Jassem, Jacek Bigda
2018-05-01

"Teachable Moment" Interventions in Lung Cancer: Why Action Matters.

Jacek Jassem

Human - wd:Q19690551

Welcome to Inventaire

de bibliotheek van je vrienden en communities

meer leren